What's to prevent patients who have failed or are refractory to methotrexate from simply using anti-TNFs or JAK inhibitors, particularly if the latter have better efficacy and/or are at least as safe as CF101?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.